• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911438250
Device Problems Occlusion Within Device (1423); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Occlusion (1984)
Event Date 01/30/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that in-stent restenosis and angina occurred.In (b)(6) 2013, the patient presented with angina and st elevated myocardial infarction.Subsequently, index procedure was performed one day later.The target lesion was a de novo lesion located in the mid left anterior descending artery with 75% stenosis and was 36 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with pre-dilatation and placement of a 2.50 x 38 mm promus element¿ plus stent.Following post dilatation, residual stenosis was 0 %.On the following day, patient was discharged on aspirin and ticagrelor.In (b)(6) 2018, the patient came for a follow-up visit with the chief complaint of worsening chest pain since last month.The patient's chest pain lasted for 5 -10 minutes with nitroglycerin, however was worst with stress and exertion.The patient's chest pain with an accelerating pattern, concerned for canadian class 4 angina and the patient was scheduled for left heart catheterization in three days.In (b)(6) 2018, the patient was sent for left heart catheterization which revealed in-stent restenosis (isr) in the 60%-70% range proximally and 30% stenosis in the distal aspect of the stent.The 60-70% isr was treated with balloon angioplasty with 10% residual stenosis and timi 3 flow.On the following day, the event was considered resolved and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the angina was not related to this device and the in-stent restenosis referred to a non-bsc drug-eluting stent deployed in the proximal left anterior descending (lad) artery.Also, there was no stenosis in mid lad.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7348685
MDR Text Key102739889
Report Number2134265-2018-01986
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/05/2013
Device Model NumberH7493911438250
Device Catalogue Number39114-3825
Device Lot Number15794626
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/20/2018
Initial Date FDA Received03/19/2018
Supplement Dates Manufacturer Received04/27/2018
Supplement Dates FDA Received05/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-